Episode
India's First Homegrown FDA Drug | Is Airtel's Fast Lane Fair? | Godrej Enters Wealth
- Podcast
- Top of the Morning
- Published
- Jun 2, 2026
- Duration seconds
- 904
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/top-of-the-morning-3714868/episodes/india-s-first-homegrown-fda-drug-is-airtel-s-fast-lane-fair-godrej-enters-wealth/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/top-of-the-morning-3714868/india-s-first-homegrown-fda-drug-is-airtel-s-fast-lane-fair-godrej-enters-wealth.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Good Morning, I'm Nelson John. Today on Top of the Morning: Godrej launches its wealth arm with a ₹1 lakh crore target. Wockhardt wins FDA approval for India's first fully homegrown new drug. The weak rupee is squeezing AI startups, and founders are getting creative. The regulator looks set to clear Airtel's priority 5G plan. And the Supreme Court closes the casino industry's tax loophole. Five stories, ten minutes, no fluff. Listen now. Learn more about your ad choices. Visit megaphone.fm/adchoices